Valuation: CStone Pharmaceuticals

Market Cap 8.18B 1.21B 1.05B 982M 897M 1.69B 116B 1.72B 11.53B 4.51B 57.87B 4.56B 4.46B 193B P/E 2026 *
-384x
P/E 2027 * 7.64x
Enterprise Value 7.65B 1.14B 982M 919M 839M 1.58B 108B 1.61B 10.78B 4.22B 54.13B 4.26B 4.17B 181B EV / Sales 2026 *
16x
EV / Sales 2027 * 2.67x
Free-Float
80.15%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: CStone Pharmaceuticals

1 day-1.41%
1 week-1.41%
Current month-1.41%
1 month-1.41%
3 months-30.69%
6 months-0.41%
Current year-21.61%
1 week 0.7
Extreme 0.7
0.7
1 month 0.7
Extreme 0.7
0.7
Current year 0.59
Extreme 0.5945
1.01
1 year 0.59
Extreme 0.5945
1.01
3 years 0.11
Extreme 0.1139
1.01
5 years 0.11
Extreme 0.1139
1.78
10 years 0
Extreme 0.0001
2.6
Manager TitleAgeSince
Chief Executive Officer 62 2022-08-24
Director of Finance/CFO - 2023-01-17
Chief Operating Officer 46 2016-07-31
Director TitleAgeSince
Chairman 55 -
Director/Board Member 62 2022-08-24
Director/Board Member 63 2021-07-08
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%-1.41% - - 1.09B
-1.37%+4.97%+41.56%+0.50% 80.69B
+2.55%+13.07%+2.40%+30.48% 51.22B
+0.49%+2.17%+22.60%+177.89% 49.58B
+2.87%+11.29%-46.98%-47.72% 45.5B
-1.56%+1.03%+56.03%-24.22% 30.6B
-0.39%+2.23%+54.45%+84.81% 24.64B
+1.27%+9.85%+131.89%-39.60% 23.88B
-1.80%+11.10%+4.71%+196.74% 21.59B
-5.89%+34.09%-0.99%+792.56% 17.09B
Average -0.66%+182.05%+29.52%+130.16% 38.31B
Weighted average by Cap. -0.08%+270.79%+25.38%+76.70%

Financials

2026 *2027 *
Net sales 479M 71.15M 61.53M 57.58M 52.58M 98.89M 6.79B 101M 676M 265M 3.39B 267M 261M 11.33B 1.71B 254M 220M 206M 188M 353M 24.27B 360M 2.42B 946M 12.13B 955M 934M 40.51B
Net income -243M -36.1M -31.22M -29.21M -26.68M -50.18M -3.45B -51.12M -343M -134M -1.72B -136M -133M -5.75B 687M 102M 88.25M 82.58M 75.41M 142M 9.74B 145M 969M 379M 4.87B 383M 375M 16.25B
Net Debt -528M -78.41M -67.81M -63.45M -57.94M -109M -7.48B -111M -745M -292M -3.74B -294M -288M -12.49B -3.6B -535M -463M -433M -395M -743M -51.04B -757M -5.08B -1.99B -25.5B -2.01B -1.96B -85.19B
Logo CStone Pharmaceuticals
CStone Pharmaceuticals is an investment holding company primarily engaged in research and development of therapies for oncology, autoimmune and inflammation, and other key disease areas. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, the sales of pharmaceutical products, as well as the provision of license of its intellectual property (IP) or commercialization license. The Company’s products primarily include targeted therapies, AYVAKIT (avapritinib), GAVRETO (pralsetinib) and CEJEMLY (sugemalimab). The Company is also engaged in the development and commercialization of immuno-oncology. The Company primarily conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.
Employees
136
Date Price Change Volume
Trader
Investor
-
Global
-
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.116CNY
Average target price
12.33CNY
Spread / Average Target
+141.03%

Quarterly revenue - Rate of surprise